1,113
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer

, , , &
Pages 1573-1578 | Received 01 May 2013, Accepted 02 Jun 2013, Published online: 19 Aug 2013

Figures & data

Table I. Comparison of DVH metrics for 3D-RT vs IMAT plans for cord, liver and kidney. For each dose constraint, the number of patients whose plans achieved the dose constraints is noted in brackets for each technique. PD = prescribed dose, NS = not significant.

Figure 1. (a) NTCP for stomach each patient using Pan parameters [Citation16]; (b) stomach D2% for each patient; and (c) average stomach NTCP for different models. TD50, m and n values are listed in Supplementary Table II: Pan [Citation16] and Burman [Citation24], or using range of values from Pan of TD50 = 53 Gy (TD50 min), m = 0.23 (m min), m = 0.39 (m max) or small bowel or combined stomach-duodenum (StoDuo) parameters.

Figure 1. (a) NTCP for stomach each patient using Pan parameters [Citation16]; (b) stomach D2% for each patient; and (c) average stomach NTCP for different models. TD50, m and n values are listed in Supplementary Table II: Pan [Citation16] and Burman [Citation24], or using range of values from Pan of TD50 = 53 Gy (TD50 min), m = 0.23 (m min), m = 0.39 (m max) or small bowel or combined stomach-duodenum (StoDuo) parameters.

Figure 2. NTCP for duodenum as calculated using the parameters for combined stomach and duodenum (StoDuo) and duodenum only (Duod) [Citation16].

Figure 2. NTCP for duodenum as calculated using the parameters for combined stomach and duodenum (StoDuo) and duodenum only (Duod) [Citation16].
Supplemental material

Supplementary Tables I and II

Download PDF (212.6 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.